Serologic response to West Nile virus vaccination in the greater one-horned rhinoceros (Rhinoceros unicornis).

The research article focuses on testing the effectiveness of two different commercial vaccines – a killed vaccine and a recombinant viral-vectored vaccine – against the West Nile virus (WNV) on the Greater One-horned rhinoceroses. Results indicate that the recombinant vaccine seems to produce a more substantial immune response.

Overview of the Research

• This study aimed to evaluate the efficacy of two commercial WNV vaccines on the Greater One-horned rhinoceros (Rhinoceros unicornis) living in North American zoos. West Nile Virus infections can be detrimental to these species, prompting zoological institutions to adopt vaccination as part of their preventative care measures.
• Both vaccines in question, a killed version and a recombinant viral-vectored vaccine, were originally produced for horses but have been used for non-domestic species. The goal here was to gauge their effectiveness on rhinoceros species.

Conducting the Study

• In the study, five rhinoceroses received the killed equine vaccine in 2005 and another group of four received booster shots of the recombinant vaccine in 2006.
• The team analyzed the changes in neutralizing antibody titer and gamma and beta globulins on serum protein electrophoresis, both pre- and post-vaccination.

Findings of the Research

• No notable changes were observed in the group that received the killed vaccine.
• In contrast, antibody titers (indicative of an immune response) were observed in two out of four rhinoceroses that received the recombinant vaccine. This suggests that the recombinant vaccine may have induced a more significant humoral immune response.

Implications and Further Research

• Based on the results, researchers concluded that the recombinant WNV vaccine appeared to be more effective in Greater One-horned rhinoceros.
• Nevertheless, they proposed further investigation to determine if variations in the frequency of administration, dosage, or the use of an adjuvant might enhance the immune response in these animals.